Clinical Trials Logo
  1. Home
  2. Facial Rhytides
  3. NCT02261493

A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

Facial Rhytides Clinical Trial

Official title:
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)

Clinical Trial Summary

This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines [crow's feet lines]).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02261493
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 3
Start date October 2014
Completion date April 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01189760 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT01224015 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02176356 - Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study) Phase 4
Completed NCT01600729 - Reliability of the Facial Wrinkle Scale in Japanese Subjects N/A
Completed NCT01391299 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines N/A
Completed NCT01777620 - A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides Phase 4
Completed NCT00842062 - Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation Phase 1/Phase 2
Completed NCT04609020 - Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment Phase 4
Completed NCT01299103 - Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles N/A
Completed NCT01608659 - An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A